36th Annual JPM Healthcare Conference

Post author:gtmrick
Post published:December 25, 2017
Post category:Uncategorized

In 2018 Vasomune Therapeutics will be at the 36TH ANNUAL JPM HEALTHCARE CONFERENCE, San Francisco, California

About

Vasomune Therapeutics is a private biotechnology company developing the next generation of medications to harness the body’s ability to defend against illness by modifying cellular response to disease.

You Might Also Like

Vasomune Receives a US $2.8 Million PRMRP Grant from the US Department of Defense to Develop AV-001 for the Treatment of ALI/ARDS of Any Cause, Including COVID-19

Vasomune is Pleased to Announce the Government of Canada’s Investment in AV-001 Targeting COVID-19

Vasomune Therapeutics and AnGes, Inc. enter into a Multi-Million Dollar Global Co-Development Agreement to Advance an Innovative Platform Targeting Vascular Leakage

About

Vasomune Therapeutics 2020 © All Rights Reserved.